Skip to Main Content

Paper Details

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet, The
48
2022
COVID 19, COVID-19, CpG, SAR-CoV, SARS, SARS CoV 2, SARS-CoV, SCB-2019, alum, delta variant, participants, sodium chloride

Datasets

Release 1.2